World Journal of
Pharmaceutical and Life Sciences

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, 

Abstract

UPASHYATMAKA STUDY TO EVALUATE THE EFFICACY OF JATAMAMANSI CHURNA & PUNARNAVA CHURNA ON VYANA BALA VAISHAMYA (HYPERTENSION

Dr. Shyamveer Ghuraiya* Prof. Dr. Pawankumar Godatwar

ABSTRACT

The WHO rates hypertension as one of the most important causes of premature death worldwide. Worldwide, approximately 1 billion people have hypertension, contributing to more than 7.1 million deaths per year. The number of adults with hypertension in 2025 is predicted to increase by about 60% to a total of around 1.56 billion. In India, Cardiovascular diseases caused 2.3 million deaths in the year 1990; this is projected to double by the year 2020. Numbers of drugs are available in modern medicine to treat the disease in its symptomatically active state but still are unable to cure the hypertension. Hyperfunction of Vyana is considered under Vyana Bala Vaishamya which produces increased force in the wall of the channels (blood vessels) to produce the disease hypertension. In the present clinical trial ‘Punarnava Churna’ and ‘Jatamansi Churna’ given orally, administered for 1 month twice a day after food. 60 clinically diagnosed patients of hypertension were selected randomly and divided into two groups. BP, CBC, RBS, ECG, Blood urea, Serum creatinine and Lipid profile were done before and after the clinical trial. After completion of study signs and symptoms were controlled significantly and also there were significant changes in laboratory findings.

[Full Text Article]

BEST PAPER AWARDS

World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue
Dr. Olajide Adedayo Ajayi

Download Article : Click here